AnalystBook Research · Company Intelligence

Scilex Holding Co

SCLXNasdaq

Built from Scilex Holding Co's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data

Scilex Holding Co: Revenue declined 46.5% to $30.25M from $56.59M. Net loss widened to $374M from $72.81M. Free cash flow declined 81% to $3.683M from $19.35M. Operating margin contracted 99634 bps to -1143.71%. Scilex Holding Co's annual comparison also shows margins improved while free cash flow declined; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.

The read at a glance✓ Audited against SEC data
  • Growth — Revenue declined 46.5% to $30.25M from $56.59MWatch
  • Profitability — Net loss widened to $374M from $72.81MWatch
  • Cash flow — Free cash flow declined 81% to $3.683M from $19.35MWatch
  • Margins — Operating margin contracted 99634 bps to -1143.71%Watch
  • Accounting — Going-concern warningWatch
  • Insiders — 0 purchases and 11 salesWatch

Business

We commercialized GLOPERBA in June 2024 and believe we are well positioned to market and distribute the product.

Leadership changes

From Scilex Holding Co's own filings, the day they're filed.

  • Stephen Ma · Chief Operating Officer · appointmenteff. 2025-10-01
  • Annu Navani · directors · departureeff. 2025-09-22
  • Jaisim Shah · directors · departureeff. 2025-09-22

Latest filings

  • 10-Q · Quarterly report2026-08-14
  • 8-K · Company announcement2026-08-12
  • 8-K · Company announcement2026-07-22
  • 8-K · Company announcement2026-07-06
  • 8-K · Company announcement2026-06-29
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Scilex Holding Co, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

See the full SCLX record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.